Cerus Corporation

CERS ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-24.1M
Depreciation & Amortization $866.0K
Depreciation —
Amortization $0
Stock-Based Compensation $2.0M
Net Cash from Operating Activities $-14.5M
Investing Activities
Capital Expenditures $191.0K
Business Acquisitions —
Net Cash from Investing Activities $9.3M
Financing Activities
Dividends Paid —
Stock Repurchases —
Net Cash from Financing Activities $12.2M
Net Change in Cash $7.0M
Free Cash Flow $-14.7M
← Newer Page 3 of 3 Older →